SREBF1 and Insulin resistance: Consequently, alb-SREBP-1c mice show a mild steatosis phenotype and selective hepatic insulin resistance due to activation of DNL and phenotypically this is accompanied by massive obesity and hepatic lipid accumulation with hepatic insulin resistance (Knebel et al., 2012; Jelenik et al., 2017).